1. Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med. 1956; 255:57–65.
Article
2. Bickerstaff ER, Cloake PC. Mesencephalitis and rhombencephalitis. Br Med J. 1951; 2:77–81.
Article
3. Ropper AH. Unusual clinical variants and signs in Guillain-Barré syndrome. Arch Neurol. 1986; 43:1150–2.
4. Ropper AH. Further regional variants of acute immune polyneuropathy. Bifacial weakness or sixth nerve paresis with paresthesias, lumbar polyradiculopathy, and ataxia with pharyngeal-cervical-brachial weakness. Arch Neurol. 1994; 51:671–5.
5. Shuaib A, Becker WJ. Variants of Guillain-Barré syndrome: Miller Fisher syndrome, facial diplegia and multiple cranial nerve palsies. Can J Neurol Sci. 1987; 14:611–6.
6. Chiba A, Kusunoki S, Shimizu T, Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol. 1992; 31:677–9.
Article
7. Yuki N, Sato S, Tsuji S. . An immunologic abnormality com-mon to Bickerstaff’s brain stem encephalitis and Fisher’s syndrome. J Neurol Sci. 1993; 118:83–7.
Article
8. Odaka M, Yuki N, Hirata K. Anti-GQ1b IgG antibody syndrome: clinical and immunological range. J Neurol Neurosurg Psychiatry. 2001; 70:50–5.
Article
9. Sohn HJ, Lee JH, Paik HJ, Chi MJ. A case of atypical Miller Fisher sndrome. J Korean Ophthalmol Soc. 2007; 48:878–82.
10. Ahn JH, Lee SG. A case of anti-GQ1b-positive atypical Miller Fisher syndrome with pupil involvement. J Korean Ophthalmol Soc. 2009; 50:645–8.
Article
11. Park IK, Moon SW, Han JS, Shin JH. A case of Miller Fischer syn-drome with optic nerve involvement. J Korean Ophthalmol Soc. 2010; 51:1676–80.
Article
12. Kim EJ, Ha SG, Kim SH. A case of Miller Fisher syndrome in a pe-diatric patient with positive anti-GQ1b IgG. J Korean Ophthalmol Soc. 2016; 57:528–31.
Article
13. Son MG, Ahn HS. Miller Fisher syndrome. J Korean Ophthalmol Soc. 1997; 38:1470–9.
14. Holmes JM, Liebermann L, Hatt SR. . Quantifying diplopia with a questionnaire. Ophthalmology. 2013; 120:1492–6.
Article
15. Goffette S, Sindic CJ. Acute isolated ophthalmoplegia associated with high levels of anti-GQ 1b antibodies. Eur Neurol. 2000; 43:120–1.
16. Goffette S, Jeanjean A, Pierret F. . Clinical relevance of the de-termination of anti-GQ1b antibodies in Miller Fisher and Guillain-Barré syndromes. Acta Neurol Belg. 1998; 98:322–6.
17. Koga M, Gilbert M, Li J. . Antecedent infection in Fisher syn-drome: a common pathogenesis of molecular mimicry. Neurology. 2005; 64:1605–11.
18. Yuki N, Koga M. Bacterial infections in Guillain-Barré and Fisher syndromes. Curr Opin Neurol. 2006; 19:451–7.
Article
19. Saul RF. Neuro-ophthalmology and the Anti-GQ1b antibody syndromes. Curr Neurol Neurosci Rep. 2009; 9:379–83.
Article
20. Yuki N, Odaka M, Hirata K. Acute ophthalmoparesis (without ataxia) associated with anti-GQ1b IgG antibody: clinical features. Ophthalmology. 2001; 108:196–200.
21. Tatsumoto M, Odaka M, Hirata K, Yuki N. Isolated abducens nerve palsy as a regional variant of Guillain-Barré syndrome. J Neurol Sci. 2006; 243:35–8.
Article
22. Koo DL, Park LH, Kim HT. . Acute monocular ophthalmoplegia associated with anti-GQ1b IgG antibody. J Korean Neurol Assoc. 2004; 22:663–5.
23. Lo YL. Clinical and immunological spectrum of the Miller Fisher syndrome. Muscle Nerve. 2007; 36:615–27.
Article
24. Sugita A, Yanagisawa T, Kamo T. . Internal ophthalmoplegia with anti-GQ1b IgG antibody. J Neurol. 2002; 249:1475–6.
Article
25. Chiba A, Kusunoki S, Obata H. . Ganglioside composition of the human cranial nerves, with special reference to pathophysiol-ogy of Miller Fisher syndrome. Brain Res. 1997; 745:32–6.
Article
26. Ilyas AA, Willison HJ, Quarles RH. . Serum antibodies to gan-gliosides in Guillain-Barré syndrome. Ann Neurol. 1988; 23:440–7.
Article
27. Kim JK, Bae JS, Kim DS. . Prevalance of anti-ganglioside anti-bodies and their clinical correlates with gullain-barré syndrome in Korea: a nationwide multicenter study. J Clin Neurol. 2014; 10:94–100.
28. Svennerholm L, Boström K, Fredman P. . Gangliosides and al-lied glycosphingolipids in human peripheral nerve and spinal cord. Biochim Biophys Acta. 1994; 1214:115–23.
Article
29. Neisser A, Bernheimer H, Berger T. . Serum antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in Miller Fisher syndrome. Infect Immun. 1997; 65:4038–42.
Article
30. Chiba A, Kusunoki S, Obata H. . Serum anti-GQ1b IgG anti-body is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology. 1993; 43:1911–7.
31. Kusunoki S. Diagnosis, pathogenesis and treatment of Miller Fisher syndrome and related disorders: clinical significance of antiGQ1b IgG antibody. Expert Rev Neurother. 2003; 3:133–40.
Article
32. Kaida K, Kanzaki M, Morita D. . Anti-ganglioside complex antibodies in Miller Fisher syndrome. J Neurol Neurosurg Psychiatry. 2006; 77:1043–6.
Article
33. Na JG, Jung WY, Won K, Lim GH. Brainstem encephalitis mim-icking Miller Fisher syndrome. J Korean Neurol Assoc. 1994; 12:758–63.
34. Kim BJ, Seo YL. Relapsing sensory ataxia initially manifested by miller-fisher syndrome. J Korean Neurol Assoc. 1997; 15:216–21.
35. Hong SN, Koo JS, Kim BK. . A case of Miller Fisher syndrome presenting as sudden vertigo. J Korean Neurol Assoc. 2000; 18:486–9.
36. Mori M, Kuwabara S, Fukutake T. . Clinical features and prog-nosis of Miller Fisher syndrome. Neurology. 2001; 56:1104–6.
Article
37. Mori M, Kuwabara S, Fukutake T, Hattori T. Intravenous im-munoglobulin therapy for Miller Fisher syndrome. Neurology. 2007; 68:1144–6.
Article